A correct product name is only the beginning of material verification. For 5-Amino-1MQ, researchers should separate chemical identity, salt or counterion form, chromatographic purity, water and residual-solvent content, and the actual amount of target compound in a container.
Key takeaways
- Confirm the exact chemical form and identifier rather than relying on an abbreviated product name.
- HPLC area purity is not automatically the same as mass fraction or assay value.
- Use lot-specific records; a generic specification cannot prove the identity of a delivered lot.
Start with an unambiguous identity record
Check the systematic name, molecular formula, molecular mass and registry identifiers against an authoritative chemical record. If a salt form is supplied, the stated formula and mass should correspond to that form rather than the neutral parent by default. Synonyms are useful for search, but they should not replace the primary identity fields.
A paper may describe a compound by an internal code, free-base form or a specific formulation. Similar naming does not prove equivalence between that experimental material and a commercial catalog item.
Read purity and assay as different measurements
Chromatographic purity usually reports the relative area of detected components under a defined method. It does not necessarily account for water, counterions, inorganic residue or every undetected impurity. Quantitative assay, water determination, residual-solvent testing and mass balance answer different questions.
For reproducible research, the certificate should name the technique and acceptance criteria rather than present a percentage without context. Raw chromatograms or spectra may be appropriate when the project requires deeper verification.
Match documentation to the lot and experiment
Confirm that the catalog number, batch number and material name agree across the label, certificate and any supporting analytical file. Record receipt condition and storage requirements. If a project depends on a particular form or impurity threshold, make that requirement explicit before procurement.
This workflow supports material traceability. It does not convert a research material into an approved drug or validate any clinical claim.
Sources & editorial method
The editorial workflow starts with linked peer-reviewed papers, trial registries or regulatory records; extracts the population or model, endpoints, numerical results and limitations; and separates the studied intervention from catalog material. AI-assisted drafting was used to structure the first version. Claims, figures, evidence labels and limitations were checked against the linked records in the site editorial workflow. This is not independent peer review.
4 linked records are listed in the references below. Read the editorial and AI-assistance policy.
How to interpret this article
Source-checked against the linked primary or authoritative records on 2026-08-27. This is an evidence summary, not independent peer review, medical advice or validation of a catalog lot.
Research-use boundary: Catalog materials discussed on this website are for laboratory research, development and manufacturing use only, not for human or veterinary use. This content is not medical advice and does not provide administration instructions.
Primary records and authoritative sources
- PubChem Compound Summary for CID 950107: 5-Amino-1-methylquinoliniumNational Center for Biotechnology Information. PubChem CID 950107; record modified July 25, 2026.
- Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in miceNeelakantan H, et al. Biochemical Pharmacology. 2018;147:141–152. PMID 29155147 · DOI 10.1016/j.bcp.2017.11.007
- ICH Q2(R2): Validation of Analytical ProceduresOfficial analytical-validation framework; not evidence that a specific catalog lot has been tested.
- ICH Q14: Analytical Procedure DevelopmentOfficial analytical-development framework; included as general method guidance only.
Continue with structured records
Move from this editorial analysis to the product identity, filtered evidence and controlled terminology behind it.
